Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.
暂无分享,去创建一个
R. Tompkins | J. Meer | C. Dinarello | J. V. D. van der Meer | D. Wilmore | H. Michie | J. Cannon | J. Gelfand | J. F. Burke | S. Wolff | S. Endres | G. Stanford | B. Chernow | G. Lonnemann | Joseph Cannon | J. Corsetti | H. R. Michie | Joseph G. Cannon
[1] J. Symons,et al. CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS , 1988, The Lancet.
[2] E. Girardin,et al. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. , 1988, The New England journal of medicine.
[3] A. Cerami,et al. Detection of circulating tumor necrosis factor after endotoxin administration. , 1988, The New England journal of medicine.
[4] L. Aarden,et al. Interleukin 6 is involved in interleukin 1‐induced activities , 1988, European journal of immunology.
[5] T. Ikejima,et al. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.
[6] J. Meer,et al. Concentrations of Immunoreactive Human Tumor Necrosis Factor Alpha Produced by Human Mononuclear Cells In Vitro , 1988, Journal of leukocyte biology.
[7] K. Tracey,et al. Cytokine appearance in human endotoxemia and primate bacteremia. , 1988, Surgery, gynecology & obstetrics.
[8] A. Teppo. SERUM IMMUNOREACTIVE INTERLEUKIN 1 IN RENAL TRANSPLANT RECIPIENTS: Association of Raised Levels With Graft Rejection Episodes1 , 1988, Transplantation.
[9] C. Griscelli,et al. SPECIFIC INTERLEUKIN-1 INHIBITOR IN SERUM AND URINE OF CHILDREN WITH SYSTEMIC JUVENILE CHRONIC ARTHRITIS , 1987, The Lancet.
[10] C. Maury,et al. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection , 1987, The Journal of experimental medicine.
[11] A. Waage,et al. ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.
[12] B. Beutler,et al. Cachectin: more than a tumor necrosis factor. , 1987, The New England journal of medicine.
[13] P. Scuderi,et al. RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONS , 1986, The Lancet.
[14] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[15] T. Luger,et al. Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis , 1986, Critical care medicine.
[16] J. Watters,et al. Both inflammatory and endocrine mediators stimulate host responses to sepsis. , 1986, Archives of surgery.
[17] B. Aggarwal,et al. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon , 1985, Nature.
[18] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[19] S. Wolff. Biological effects of bacterial endotoxins in man. , 1973, The Journal of infectious diseases.
[20] J. Gallin,et al. Serum lipids in infection. , 1969, The New England journal of medicine.
[21] C. Dinarello,et al. New concepts on the pathogenesis of fever. , 1988, Reviews of infectious diseases.
[22] C. Dinarello,et al. Development and use of a radioimmunoassay for human interleukin-1 beta. , 1987, Lymphokine research.